O	O	O	0	2	An	An	B-NP	DT	O	3	NMOD	O
O	O	O	3	13	allosteric	allosteric	I-NP	JJ	O	3	NMOD	O
O	O	O	14	18	drug	drug	I-NP	NN	O	12	NMOD	O
O	O	O	18	19	,	,	O	,	O	12	P	O
O	O	O	20	21	o	o	B-NP	NN	O	12	NMOD	O
O	O	O	21	22	,	,	O	,	O	12	P	O
O	O	O	22	23	o	o	B-NP	NN	O	12	NMOD	O
O	O	O	23	24	'	'	B-NP	SYM	O	12	NMOD	O
O	O	O	24	25	-	-	I-NP	HYPH	O	12	NMOD	O
O	O	O	25	37	bismyristoyl	bismyristoyl	I-NP	NN	O	12	NMOD	O
O	O	O	38	46	thiamine	thiamine	I-NP	NN	O	12	NMOD	O
O	O	O	47	56	disulfide	disulfide	I-NP	NN	O	14	SUB	O
O	O	O	56	57	,	,	O	,	O	12	P	O
O	O	O	58	68	suppresses	suppress	B-VP	VBZ	O	0	ROOT	O
O	O	O	69	72	HIV	HIV	B-NP	NN	O	18	NMOD	O
O	O	O	72	73	-	-	B-NP	HYPH	O	18	NMOD	O
O	O	O	73	74	1	1	I-NP	CD	O	18	NMOD	O
O	O	O	75	86	replication	replication	I-NP	NN	O	14	OBJ	O
O	O	O	87	94	through	through	B-PP	IN	O	14	VMOD	O
O	O	O	95	105	prevention	prevention	B-NP	NN	O	19	PMOD	O
O	O	O	106	108	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	109	116	nuclear	nuclear	B-NP	JJ	O	23	NMOD	O
O	O	O	117	130	translocation	translocation	I-NP	NN	O	21	PMOD	O
O	O	O	131	133	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	134	138	both	both	O	CC	O	34	NMOD	O
O	O	O	139	142	HIV	HIV	B-NP	NN	B-protein	29	NMOD	B-protein
O	O	O	142	143	-	-	B-NP	HYPH	I-protein	29	NMOD	I-protein
O	O	O	143	144	1	1	I-NP	CD	I-protein	29	NMOD	I-protein
T1	B-Protein	B-Protein	145	148	Tat	Tat	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	O	149	152	and	and	I-NP	CC	O	34	NMOD	O
T3	B-Entity	B-Entity	153	155	NF	NF	I-NP	NN	B-protein	34	NMOD	B-protein
T3	I-Entity	I-Entity	155	156	-	-	B-NP	HYPH	I-protein	34	NMOD	I-protein
T3	I-Entity	I-Entity	156	161	kappa	kappa	I-NP	NN	I-protein	34	NMOD	I-protein
T3	I-Entity	I-Entity	162	163	B	B	I-NP	NN	I-protein	24	PMOD	I-protein
O	O	O	163	164	.	.	O	.	O	14	P	O

O	O	O	166	169	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	170	178	efficacy	efficacy	I-NP	NN	O	0	ROOT	O
O	O	O	179	181	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	182	183	o	o	B-NP	NN	O	15	SUB	O
O	O	O	183	184	,	,	O	,	O	15	P	O
O	O	O	184	185	o	o	B-NP	NN	O	15	SUB	O
O	O	O	185	186	'	'	B-NP	SYM	O	6	NMOD	O
O	O	O	186	187	-	-	I-NP	HYPH	O	7	AMOD	O
O	O	O	187	199	bismyristoyl	bismyristoyl	I-NP	NN	O	11	NMOD	O
O	O	O	200	208	thiamine	thiamine	I-NP	NN	O	11	NMOD	O
O	O	O	209	218	disulfide	disulfide	I-NP	NN	O	8	NMOD	O
O	O	O	219	220	(	(	O	(	O	14	DEP	O
O	O	O	220	223	BMT	BMT	B-NP	NN	O	14	DEP	O
O	O	O	223	224	)	)	O	)	O	11	NMOD	O
O	O	O	225	228	was	be	B-VP	VBD	O	3	SBAR	O
O	O	O	229	237	examined	examine	I-VP	VBN	O	15	VC	O
O	O	O	238	240	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	241	247	detail	detail	B-NP	NN	O	17	PMOD	O
O	O	O	248	255	against	against	B-PP	IN	O	18	NMOD	O
O	O	O	256	259	HIV	HIV	B-NP	NN	O	24	NMOD	O
O	O	O	259	260	-	-	B-NP	HYPH	O	24	NMOD	O
O	O	O	260	261	1	1	I-NP	CD	O	24	NMOD	O
O	O	O	262	272	laboratory	laboratory	I-NP	NN	O	24	NMOD	O
O	O	O	273	281	isolates	isolate	I-NP	NNS	O	47	NMOD	O
O	O	O	282	283	(	(	O	(	O	34	DEP	O
O	O	O	283	287	HTLV	HTLV	B-NP	NN	O	33	NMOD	O
O	O	O	287	288	-	-	O	HYPH	O	33	P	O
O	O	O	288	292	IIIB	IIIB	B-NP	NN	B-protein	33	NMOD	B-protein
O	O	O	292	293	,	,	O	,	O	33	P	O
O	O	O	294	298	JRFL	JRFL	B-NP	NN	B-protein	33	NMOD	B-protein
O	O	O	298	299	,	,	O	,	O	33	P	O
O	O	O	300	303	and	and	O	CC	O	33	NMOD	O
O	O	O	304	306	MN	MN	B-NP	NN	B-protein	34	DEP	B-protein
O	O	O	306	307	)	)	O	)	O	24	NMOD	O
O	O	O	307	308	,	,	O	,	O	47	P	O
O	O	O	309	316	primary	primary	B-NP	JJ	O	37	NMOD	O
O	O	O	317	325	isolates	isolate	I-NP	NNS	O	47	NMOD	O
O	O	O	326	327	(	(	O	(	O	42	DEP	O
O	O	O	327	330	KMT	KMT	B-NP	NN	O	41	NMOD	O
O	O	O	331	334	and	and	O	CC	O	41	NMOD	O
O	O	O	335	338	KMO	KMO	B-NP	NN	B-protein	42	DEP	B-protein
O	O	O	338	339	)	)	O	)	O	37	NMOD	O
O	O	O	339	340	,	,	O	,	O	47	P	O
O	O	O	341	344	and	and	O	CC	O	47	NMOD	O
O	O	O	345	351	simian	simian	B-NP	JJ	O	47	NMOD	O
O	O	O	352	368	immunodeficiency	immunodeficiency	I-NP	NN	O	47	NMOD	O
O	O	O	369	374	virus	virus	I-NP	NN	O	19	PMOD	O
O	O	O	375	376	(	(	O	(	O	50	DEP	O
O	O	O	376	385	SIVmac251	SIVmac251	B-NP	NN	O	50	DEP	O
O	O	O	385	386	)	)	O	)	O	47	NMOD	O
O	O	O	387	389	in	in	B-ADVP	FW	O	16	VMOD	O
O	O	O	390	395	vitro	vitro	I-ADVP	FW	O	51	AMOD	O
O	O	O	395	396	.	.	O	.	O	2	P	O

O	O	O	397	400	BMT	BMT	B-NP	NN	O	2	SUB	O
O	O	O	401	410	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	O	411	414	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	415	426	replication	replication	I-NP	NN	O	7	NMOD	O
O	O	O	427	429	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	430	433	HIV	HIV	B-NP	NN	O	5	PMOD	O
O	O	O	433	434	-	-	B-NP	HYPH	O	2	P	O
O	O	O	434	435	1	1	I-NP	CD	O	2	VMOD	O
O	O	O	436	438	in	in	B-PP	IN	O	8	NMOD	O
O	O	O	439	443	both	both	O	CC	O	13	AMOD	O
O	O	O	444	454	laboratory	laboratory	B-NP	NN	O	13	AMOD	O
O	O	O	455	458	and	and	O	CC	O	13	AMOD	O
O	O	O	459	466	primary	primary	B-NP	JJ	O	14	NMOD	O
O	O	O	467	475	isolates	isolate	I-NP	NNS	O	9	PMOD	O
O	O	O	476	478	in	in	B-ADVP	FW	O	2	VMOD	O
O	O	O	479	484	vitro	vitro	I-ADVP	FW	O	15	AMOD	O
O	O	O	484	485	.	.	O	.	O	2	P	O

O	O	O	486	488	In	In	B-PP	IN	O	5	VMOD	O
O	O	O	489	497	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	O	497	498	,	,	O	,	O	5	P	O
O	O	O	499	502	BMT	BMT	B-NP	NN	O	5	SUB	O
O	O	O	503	512	exhibited	exhibit	B-VP	VBD	O	0	ROOT	O
O	O	O	513	522	antiviral	antiviral	B-NP	JJ	O	7	NMOD	O
O	O	O	523	531	activity	activity	I-NP	NN	O	5	OBJ	O
O	O	O	532	539	against	against	B-PP	IN	O	7	NMOD	O
O	O	O	540	549	SIVmac251	SIVmac251	B-NP	NN	O	8	PMOD	O
O	O	O	549	550	.	.	O	.	O	5	P	O

O	O	O	551	561	Minimizing	Minimize	B-VP	VBG	O	3	NMOD	O
O	O	O	562	568	energy	energy	B-NP	NN	O	3	NMOD	O
O	O	O	569	576	studies	study	I-NP	NNS	O	7	SUB	O
O	O	O	577	579	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	580	583	BMT	BMT	B-NP	NN	O	6	NMOD	O
O	O	O	584	593	structure	structure	I-NP	NN	O	4	PMOD	O
O	O	O	594	600	reveal	reveal	B-VP	VBP	O	0	ROOT	O
O	O	O	601	605	that	that	B-SBAR	IN	O	7	VMOD	O
O	O	O	606	607	a	a	B-NP	DT	O	25	SUB	O
O	O	O	608	613	trans	trans	I-NP	AFX	O	9	NMOD	O
O	O	O	613	614	-	-	I-NP	HYPH	O	10	PMOD	O
O	O	O	614	623	disulfide	disulfide	I-NP	NN	O	11	PMOD	O
O	O	O	624	626	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	627	635	thiamine	thiamine	B-NP	NN	O	19	NMOD	O
O	O	O	636	637	(	(	O	(	O	18	DEP	O
O	O	O	637	641	holo	holo	B-NP	NN	O	17	NMOD	O
O	O	O	642	646	drug	drug	I-NP	NN	O	18	DEP	O
O	O	O	646	647	)	)	O	)	O	14	NMOD	O
O	O	O	648	657	disulfide	disulfide	B-NP	NN	O	13	PMOD	O
O	O	O	658	659	(	(	O	(	O	24	DEP	O
O	O	O	659	662	TDS	TDS	B-NP	NN	O	23	NMOD	O
O	O	O	662	663	,	,	I-NP	,	O	23	P	O
O	O	O	664	673	protodrug	protodrug	I-NP	NN	O	24	DEP	O
O	O	O	673	674	)	)	O	)	O	19	NMOD	O
O	O	O	675	677	is	be	B-VP	VBZ	O	8	SBAR	O
O	O	O	678	692	allosterically	allosterically	I-VP	RB	O	25	VMOD	O
O	O	O	693	702	transited	transit	I-VP	VBN	O	25	VC	O
O	O	O	703	705	to	to	B-PP	TO	O	27	VMOD	O
O	O	O	706	709	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	710	718	reactive	reactive	I-NP	JJ	O	32	NMOD	O
O	O	O	719	726	twisted	twisted	I-NP	JJ	O	32	NMOD	O
O	O	O	727	736	disulfide	disulfide	I-NP	NN	O	28	PMOD	O
O	O	O	737	739	of	of	B-PP	IN	O	32	NMOD	O
O	O	O	740	743	BMT	BMT	B-NP	NN	O	33	PMOD	O
O	O	O	744	745	(	(	O	(	O	38	DEP	O
O	O	O	745	749	allo	allo	B-NP	NN	O	37	NMOD	O
O	O	O	750	754	drug	drug	I-NP	NN	O	38	DEP	O
O	O	O	754	755	)	)	O	)	O	34	NMOD	O
O	O	O	756	758	by	by	B-PP	IN	O	27	VMOD	O
O	O	O	759	760	o	o	B-NP	NN	O	46	NMOD	O
O	O	O	760	761	,	,	O	,	O	46	P	O
O	O	O	761	762	o	o	B-NP	NN	O	46	NMOD	O
O	O	O	762	763	'	'	B-NP	SYM	O	46	NMOD	O
O	O	O	763	764	-	-	I-NP	HYPH	O	46	NMOD	O
O	O	O	764	776	bismyristoyl	bismyristoyl	I-NP	NN	O	46	NMOD	O
O	O	O	777	791	esterification	esterification	I-NP	NN	O	39	PMOD	O
O	O	O	792	794	of	of	B-PP	IN	O	46	NMOD	O
O	O	O	795	798	TDS	TDS	B-NP	NN	B-protein	47	PMOD	B-protein
O	O	O	798	799	.	.	O	.	O	7	P	O

O	O	O	800	803	BMT	BMT	B-NP	NN	O	2	SUB	O
O	O	O	804	812	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	O	813	820	nuclear	nuclear	B-NP	JJ	O	4	NMOD	O
O	O	O	821	834	translocation	translocation	I-NP	NN	O	2	OBJ	O
O	O	O	835	837	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	838	842	both	both	O	CC	O	5	PMOD	O
O	O	O	843	846	HIV	HIV	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	846	847	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
O	O	O	847	848	1	1	I-NP	CD	I-protein	10	NMOD	I-protein
O	O	O	849	863	transactivator	transactivator	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	864	865	(	(	O	(	O	13	DEP	O
T2	B-Protein	B-Protein	865	868	TAT	TAT	B-NP	NN	B-protein	13	DEP	B-protein
O	O	O	868	869	)	)	O	)	O	10	NMOD	O
O	O	O	870	873	and	and	O	CC	O	21	NMOD	O
O	O	O	874	877	the	the	B-NP	DT	O	19	NMOD	O
T4	B-Entity	B-Entity	878	886	cellular	cellular	I-NP	JJ	B-protein	19	NMOD	B-protein
T4	I-Entity	I-Entity	887	902	transcriptional	transcriptional	I-NP	JJ	I-protein	19	NMOD	I-protein
T4	I-Entity	I-Entity	903	910	nuclear	nuclear	I-NP	JJ	I-protein	19	NMOD	I-protein
T4	I-Entity	I-Entity	911	917	factor	factor	I-NP	NN	I-protein	21	NMOD	I-protein
T4	I-Entity	I-Entity	917	918	-	-	O	HYPH	O	21	P	O
T4	I-Entity	I-Entity	918	920	KB	KB	B-NP	NN	O	6	PMOD	O
O	O	O	921	922	(	(	O	(	O	27	DEP	O
T5	B-Entity	B-Entity	922	924	NF	NF	B-NP	NN	B-protein	26	NMOD	B-protein
T5	I-Entity	I-Entity	924	925	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
T5	I-Entity	I-Entity	925	930	kappa	kappa	I-NP	NN	I-protein	26	NMOD	I-protein
T5	I-Entity	I-Entity	931	932	B	B	I-NP	NN	I-protein	27	DEP	I-protein
O	O	O	932	933	)	)	O	)	O	21	NMOD	O
O	O	O	933	934	,	,	O	,	O	21	P	O
O	O	O	935	944	resulting	result	B-VP	VBG	O	21	NMOD	O
O	O	O	945	947	in	in	B-PP	IN	O	29	VMOD	O
O	O	O	948	951	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	952	963	suppression	suppression	I-NP	NN	O	30	PMOD	O
O	O	O	964	966	of	of	B-PP	IN	O	32	NMOD	O
O	O	O	967	970	HIV	HIV	B-NP	NN	O	37	NMOD	O
O	O	O	970	971	-	-	B-NP	HYPH	O	37	NMOD	O
O	O	O	971	972	1	1	I-NP	CD	O	37	NMOD	O
O	O	O	973	984	replication	replication	I-NP	NN	O	33	PMOD	O
O	O	O	984	985	.	.	O	.	O	2	P	O
